JEE YOUNG CHOI: Open Payments
NPI 1316352750 · ELLICOTT CITY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 23 payments from 7 companies in 2025. Trend: 2023 $557 · 2024 $663 · 2025 $691
Food & beverage: $592Education: $99
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 7 | $247 |
| United Therapeutics Corporation | 7 | $192 |
| Merck Sharp & Dohme LLC | 4 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Liquidia Technologies, Inc. | 1 | $33 |
| Abbott Laboratories | 1 | $24 |
| Sandoz Inc. | 1 | $15 |
Products named: UPTRAVI, OPSUMIT, REMODULIN, Tyvaso, Adempas, YUTREPIA, Orenitram, THORATEC HEARTMATE 3 LVAS IMPLANT KIT.
Industry payments across MD — which companies pay providers there.
